UBE3B Antibody (OTI4E4)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-44891
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 Clone # OTI4E4
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Human recombinant protein fragment corresponding to amino acids 768-1068 of human UBE3B (NP_569733) produced in E.coli.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Scientific Data Images for UBE3B Antibody (OTI4E4)
Western Blot:UBE3B Antibody (OTI4E4)[NBP3-44891]
Western Blot:UBE3B Antibody (OTI4E4)[NBP3-44891]Western Blot;UBE3B Antibody (OTI4E4)[NBP3-44891]-
HEK293T cells were transfected with the pCMV6-ENTRY control ( Left lane) or pCMV6-ENTRY UBE3B ( Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-UBE3B (1:2000). Positive lysatesApplications for UBE3B Antibody (OTI4E4)
Application
Recommended Usage
Western Blot
1:2000
Formulation, Preparation, and Storage
Purification
>95%
Formulation
PBS (pH 7.3) 1% BSA, 50% glycerol
Preservative
0.02% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20 degrees C. Avoid freeze/thaw cycles.
Background: UBE3B
Alternate Names
DKFZp586K2123, DKFZp686A1051, EC 6.3.2, EC 6.3.2.-, FLJ45294, MGC131858, MGC78388, ubiquitin protein ligase E3B, ubiquitin-protein ligase E3B
Gene Symbol
UBE3B
Additional UBE3B Products
Product Documents for UBE3B Antibody (OTI4E4)
Product Specific Notices for UBE3B Antibody (OTI4E4)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...